N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients

doi:10.12998/wjcc.v10.i2.448

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3782)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

181

WORD

HTML

1937

Figures (1-3)

196

Tables (1-1)

202

Sum=2566

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

207

Download

504

Sum=711

Publishing Process of This Article

Item

Count

Browse

195

Download

310

Sum=505

Jan 14, 2022 (publication date) through May 13, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jan 14, 2022; 10(2): 448-457
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.448

Full Size Figure Download Figure

Figure 3 Leukocyte N6-methyladenine DNA level is associated with Montreal Cognitive Assessment score. We analyzed the correlation between the Montreal Cognitive Assessment score and peripheral blood m6A levels and found that there was a significant correlation between the two in the tested population (r = 0.143, P = 0.01; < 0.05). NC: Normal control; AD: Alzheimer’s disease.

Citation: Lv S, Zhou X, Li YM, Yang T, Zhang SJ, Wang Y, Jia SH, Peng DT. N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients. World J Clin Cases 2022; 10(2): 448-457
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/448.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.448